New combo attack on Tough-to-Treat blood cancer
NCT ID NCT06572605
Summary
This study is testing if a new combination treatment is safe and effective for people with a hard-to-treat form of multiple myeloma that has spread to soft tissues. It combines a targeted cancer drug (talquetamab) with a short course of focused radiation aimed at one of the cancer's growths outside the bone. The goal is to see if this two-part approach can better control the disease in up to 20 participants who have already tried several other standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.